Virtu Financial LLC Makes New Investment in Cardlytics, Inc. (NASDAQ:CDLX)

Virtu Financial LLC purchased a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 16,729 shares of the company’s stock, valued at approximately $62,000.

A number of other hedge funds have also recently made changes to their positions in the business. RBF Capital LLC lifted its stake in Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after purchasing an additional 369,620 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after buying an additional 73,484 shares during the period. Barclays PLC lifted its stake in shares of Cardlytics by 223.9% in the 3rd quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after acquiring an additional 40,112 shares during the last quarter. SG Americas Securities LLC lifted its stake in shares of Cardlytics by 38.2% in the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after acquiring an additional 5,392 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new position in Cardlytics during the 3rd quarter worth approximately $153,000. 68.10% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CFO Alexis Desieno sold 8,854 shares of the stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $32,494.18. Following the completion of the transaction, the chief financial officer now directly owns 121,976 shares in the company, valued at $447,651.92. This trade represents a 6.77 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Amit Gupta sold 46,857 shares of Cardlytics stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the transaction, the chief executive officer now directly owns 418,637 shares of the company’s stock, valued at approximately $1,423,365.80. This trade represents a 10.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is owned by corporate insiders.

Cardlytics Trading Down 1.6 %

CDLX opened at $1.82 on Tuesday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics, Inc. has a 52 week low of $1.77 and a 52 week high of $15.89. The stock has a market cap of $94.79 million, a PE ratio of -0.30 and a beta of 1.62. The business has a 50 day moving average of $2.78 and a 200-day moving average of $3.38.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on CDLX shares. Evercore ISI cut their price target on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating on the stock in a report on Thursday, March 13th. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Finally, Lake Street Capital cut their price objective on Cardlytics from $5.00 to $3.00 and set a “hold” rating on the stock in a research report on Thursday, March 13th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and an average price target of $6.42.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.